Showing results (11-20 of 152) with videos related to
Sort By:
Pageof 16
Expert Opinion on Therapeutic Patents|October 21, 2017
A patent review of Monoacylglycerol Lipase (MAGL) inhibitors (2013-2017)Carlotta Granchi, Isabella Caligiuri, Filippo Minutolo, et al.Molecules (Basel, Switzerland)|May 11, 2024
The Benzoylpiperidine Fragment as a Privileged Structure in Medicinal Chemistry: A Comprehensive ReviewGiulia Bononi, Chiara Lonzi, Tiziano Tuccinardi, et al.Molecules (Basel, Switzerland)|December 14, 2017
Three-Dimensional Analysis of the Interactions between hLDH5 and Its InhibitorsGiulio Poli, Carlotta Granchi, Mohamed Aissaoui, et al.Expert Opinion on Therapeutic Patents|October 3, 2024
A patent review of lactate dehydrogenase inhibitors (2014-present)Giulia Bononi, Valeria Di Bussolo, Tiziano Tuccinardi, et al.Journal of Enzyme Inhibition and Medicinal Chemistry|September 30, 2014
Receptor-based virtual screening evaluation for the identification of estrogen receptor β ligandsTiziano Tuccinardi, Giulio Poli, Marco Dell'Agnello, et al.Seminars in Cancer Biology|July 9, 2022
Historical perspective of tumor glycolysis: A century with Otto WarburgGiulia Bononi, Samuele Masoni, Valeria Di Bussolo, et al.Pharmaceutical Research|July 11, 2018
Effect of Tumor Relevant Acidic Environment in the Interaction of a N-hydroxyindole-2-Carboxylic Derivative with the Phospholipid BilayerDaniela Monti, Silvia Tampucci, Erica Zucchetti, et al.Methods in Molecular Biology (Clifton, N.J.)|July 25, 2018
Rational Development of MAGL InhibitorsCarlotta Granchi, Flavio Rizzolio, Isabella Caligiuri, et al.Expert Opinion on Therapeutic Patents|October 21, 2020
An updated patent review of monoacylglycerol lipase (MAGL) inhibitors (2018-present)Giulia Bononi, Giulio Poli, Flavio Rizzolio, et al.International Journal of Pharmaceutics|August 6, 2022
MAGL inhibitor NanoMicellar formulation (MAGL-NanoMicellar) for the development of an antiglaucoma eye dropPatrizia Chetoni, Susi Burgalassi, Erica Zucchetti, et al.Pageof 16